Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study. - Wikidata - wikimedia - TriplyDB

Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.

Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.

http://www.wikidata.org/entity/Q40079134

about

Risk factors for osteoporosis in inflammatory bowel disease patients Bone and TNF in rheumatoid arthritis: clinical implications Biologic therapies and bone loss in rheumatoid arthritis.Bisphosphonates and glucocorticoid-induced osteoporosis: cons.OsteoRheumatology: a new discipline?Glucocorticoids: bad or safe for the bones?Long-term treatment of rheumatoid arthritis with adalimumab.Management of osteoporosis in rheumatoid arthritis patients.Selective COX-2 Inhibitor (Meloxicam) and Tooth-Supporting Bone Quality. A Histomorphometric Study in Rats.The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss.Decreased quantity and quality of the periarticular and nonperiarticular bone in patients with rheumatoid arthritis: a cross-sectional HR-pQCT study.Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.Re-evaluating osteoporosis and fracture risk in Crohn's disease patients in the era of TNF-alpha inhibitors.Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort.Are glucocorticoids harmful to bone in early rheumatoid arthritis?

P2860

Q26776142-245F2980-88E6-4402-BB24-28CE62D6F7E8 Q26777895-E445F10B-D783-4B72-A23F-1B7B16F08C73 Q30243911-96BF4D37-00D4-444A-895A-4F6D6A833A92 Q35882427-0D32B5F5-81DF-4A46-91F7-89D7608D6841 Q36246080-89287B6E-B951-4AD7-B6AD-E9191A225C20 Q36246088-D01DC467-83B3-4EE1-BC22-715431778527 Q37358278-5427252E-5A95-48C7-AD23-754E7F42D241 Q38334318-44F641B3-C402-449B-8A91-29F388F7D13F Q38792812-D69FD306-522A-40C8-9FC2-23DD618867BA Q38831693-7341703A-2C72-498B-9B11-6B1FDE0A3E7E Q38904535-F8A49CDB-CBAF-4204-9012-3C22088B015B Q41236945-1A33ED09-B8FA-4343-AAAC-D5033ED70D03 Q44303831-6D754A6B-C502-4DD3-BE97-A3550F60888D Q46671185-4F027A1A-9BF2-4AB7-BD71-53E42C48D15B Q47110800-58E17D5C-BC8F-4A43-BF50-5E01AE7FC1EB Q47174371-1288E57C-7367-466B-BD34-DA047519E124 Q48503661-357EEF56-06C5-4069-8DC2-582DDAE09AC7 Q51741238-866D5539-78B0-4D92-A1F0-B03B78B9B356

P2860

Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.

http://www.wikidata.org/entity/Q40079134

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Changes in bone mineral densit ...... oid arthritis: a cohort study.

@en

type

label

Changes in bone mineral densit ...... oid arthritis: a cohort study.

@en

prefLabel

Changes in bone mineral densit ...... oid arthritis: a cohort study.

@en

P1433

Q40079134-47B35D5C-B7CE-4DCA-AB3F-01E776458AC4

P1476

Q40079134-0BF28C81-A728-43EC-A46C-DA9C54881BDA

P2093

Q40079134-08B13606-8568-4E51-9E9D-7E022D09AC33

Q40079134-350EA222-EB9B-4EC8-AB3A-55DEC0ECF8ED

Q40079134-A4247F0F-F7F0-403E-A105-7DBECAA12AE6

Q40079134-D1DF2547-28EC-4519-B420-1E24B34748E1

P2860

Q40079134-134FC6A2-85F8-4ED7-91D0-B99A59963333

Q40079134-24F0F5D6-227D-47D9-9283-DEECA783EAC1

Q40079134-58F83229-0453-4B9B-A808-2DB7BAAC30B2

Q40079134-6BB0E37F-B7F8-4A75-ADE0-543760083A66

Q40079134-6DE17C5A-0BDC-45DD-9BA6-03AD92A0A91B

Q40079134-76CD79F5-2A42-41EE-B12F-C3A3AAEAEC9F

Q40079134-9D00A315-0334-49F1-9E97-625ACC9D5878

Q40079134-A96ABC40-3384-4B99-BB2C-C7BF3F09A217

Q40079134-AEDC64A9-028F-4221-90CB-D07D13FC5786

Q40079134-B3FEB63B-2C4B-45C8-9038-DDD3588C9487

P304

Q40079134-E35FEAA7-1911-4C1B-83EB-AE3DB264DBDC

P31

Q40079134-F47AC550-77D9-4CB9-9B4C-F8833CD280AD

P356

Q40079134-8FD90B68-BFB4-4E71-8E15-DCA51A105CCE

P433

Q40079134-B4AA5BBE-0635-44BB-95BC-FCB8BE3320EB

P478

Q40079134-C6222DBF-A2B3-4709-B324-89294D10AB3C

P577

Q40079134-C344B8A3-7BE6-4076-A770-BF1A93496823

P5875

Q40079134-BD2C7794-8C5D-4136-9757-D738697D93B0

P698

Q40079134-7780460E-FD92-4F02-94B9-82D1A7035D6F

P921

Q40079134-97F26C0F-1FD2-4FBA-8E8F-157D0A43B14E

P356

P1433

P1476

Changes in bone mineral densit ...... oid arthritis: a cohort study.

@en

P2093

Charlotte L M Krieckaert

http://www.w3.org/2001/XMLSchema#string

Gertjan Wolbink

http://www.w3.org/2001/XMLSchema#string

Michael T Nurmohamed

http://www.w3.org/2001/XMLSchema#string

Willem F Lems

http://www.w3.org/2001/XMLSchema#string

P2860

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.

Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months

Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis.

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab.

Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss

Bone remodeling in rheumatic disease: a question of balance.

Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis.

P304

547-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KES320

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233879451

http://www.w3.org/2001/XMLSchema#string

P698

23221326

http://www.w3.org/2001/XMLSchema#string

P921